Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

HAEMATO AG (HAEK.DE)

XETRA - XETRA Delayed Price. Currency in EUR
Add to watchlist
24.200.00 (0.00%)
At close: 05:36PM CET
Advertisement

HAEMATO AG

Lilienthalstrasse 5c
Schönefeld 12529
Germany
49 30 897 30 86 70
https://www.haemato.ag

Sector(s)Healthcare
IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees147

Key Executives

NameTitlePayExercisedYear Born
Mr. Patrick BrenskeMember of Management BoardN/AN/AN/A
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

HAEMATO AG, together with its subsidiaries, operates in the pharmaceutical sector in Germany. The company distributes European imported drugs and medical products; and manufactures and distributes its own generic medicinal products. It provides pharmaceuticals in the areas of oncology, HIV/AIDS, rheumatism, neurology, and cardiovascular diseases; and products for aesthetic treatments. The company also develops and markets medical devices and medical technology products for aesthetic surgery and cosmetic dermatology. It serves wholesalers and pharmacies, as well as doctors, clinics, medical laboratories, and hospitals. The company was founded in 1993 and is headquartered in Schönefeld, Germany.

Corporate Governance

HAEMATO AG’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement